Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Filter
  • 1-10 of  4,497 results for ""hodgkin lymphoma""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Clozapine is associated with an increased risk of Hodgkin and non-Hodgkin lymphoma.

  • Authors : Frey C; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Etminan M

  • Source: Leukemia & lymphoma [Leuk Lymphoma] 2025 Feb 12, pp. 1-3. Date of Electronic Publication: 2025 Feb 12.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

GATA3 Immunohistochemical Staining in Classical Hodgkin Lymphoma and Its Diagnostic Utility in Differential Diagnosis

  • Authors : Altay AY; İstanbul University, İstanbul Faculty of Medicine, Department of Pathology, İstanbul, Türkiye; Yeni Erdem B

Subjects: GATA3 Transcription Factor*/GATA3 Transcription Factor*/GATA3 Transcription Factor*/analysis ; GATA3 Transcription Factor*/GATA3 Transcription Factor*/GATA3 Transcription Factor*/metabolism ; Hodgkin Disease*/Hodgkin Disease*/Hodgkin Disease*/diagnosis

  • Source: Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2025 Feb 28; Vol. 42 (1), pp. 9-14. Date of Electronic Publication: 2024 Oct Publisher: Galenos Yayinevi Country of Publication: Turkey NLM ID: 9606065 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Health-Related Quality of Life in Long-Term Survivors of Non-Hodgkin Lymphoma: A French Population-Based Study.

  • Authors : Wasse SK; Registry of Hematological Malignancies of Côte d'Or, Dijon-Bourgogne University Hospital, 21000 Dijon, France.; INSERM, UMR1231, Bourgogne Franche-Comté University, 21000 Dijon, France.

  • Source: Cancers [Cancers (Basel)] 2025 Feb 19; Vol. 17 (4). Date of Electronic Publication: 2025 Feb 19.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print)

Record details

×
Academic Journal

Outcomes of Allogeneic Stem Cell Transplant in Patients with Relapsed/Refractory Hodgkin Lymphoma.

  • Authors : Ge S; Department of Medicine, McMaster University, Hamilton, ON L8N 3Z5, Canada.; Lepic K

Subjects: Hodgkin Disease*/Hodgkin Disease*/Hodgkin Disease*/therapy ; Hodgkin Disease*/Hodgkin Disease*/Hodgkin Disease*/mortality ; Hodgkin Disease*/Hodgkin Disease*/Hodgkin Disease*/drug therapy

  • Source: Current oncology (Toronto, Ont.) [Curr Oncol] 2025 Feb 18; Vol. 32 (2). Date of Electronic Publication: 2025 Feb 18.Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729

Record details

×
Academic Journal

Quantitative Proteomics and Molecular Mechanisms of Non-Hodgkin Lymphoma Mice Treated with Incomptine A, Part II.

  • Authors : García-Hernández N; Unidad de Investigación Médica en Genética Humana, UMAE Hospital Pediatría 2° Piso, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Av. Cuauhtémoc 330, Col. Doctores, Mexico City 06725, Mexico.; Calzada F

  • Source: Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2025 Feb 11; Vol. 18 (2). Date of Electronic Publication: 2025 Feb 11.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238453 Publication Model: Electronic Cited Medium: Print ISSN: 1424-8247 (Print)

Record details

×
Academic Journal

Modified Endothelial Activation and Stress Index: A New Predictor for Survival Outcomes in Classical Hodgkin Lymphoma Treated with Doxorubicin-Bleomycin-Vinblastine-Dacarbazine-Based Therapy.

  • Authors : Hunutlu FÇ; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Bursa Uludag University, Bursa 16059, Turkey.; Öztop H

  • Source: Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2025 Jan 14; Vol. 15 (2). Date of Electronic Publication: 2025 Jan 14.Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101658402 Publication Model: Electronic Cited Medium: Print ISSN: 2075-4418

Record details

×
Academic Journal

Safety and efficacy of anti-CD30 CAR-T cell therapy in relapsed/refractory classic Hodgkin lymphoma: a systematic review and meta-analysis.

  • Authors : Meng F; Department of Hematology, Daping Hospital, Third Military Medical University (Army Medical University), No.10, Daping Changjiang Branch Road, Yuzhong District, Chongqing, 400042, China.; Xiang M

Subjects: Hodgkin Disease*/Hodgkin Disease*/Hodgkin Disease*/therapy ; Hodgkin Disease*/Hodgkin Disease*/Hodgkin Disease*/immunology ; Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/adverse effects

  • Source: BMC cancer [BMC Cancer] 2025 Jan 14; Vol. 25 (1), pp. 78. Date of Electronic Publication: 2025 Jan 14.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

×
Academic Journal

Impact of Comorbidities on Prognosis and Treatment Outcomes in Elderly Patients with Hodgkin Lymphoma.

  • Authors : Tóthfalusi D; Division of Haematology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.; Doctoral School of Clinical Medicine, University of Debrecen, 4032 Debrecen, Hungary.

  • Source: Clinics and practice [Clin Pract] 2025 Jan 13; Vol. 15 (1). Date of Electronic Publication: 2025 Jan 13.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101563282 Publication Model: Electronic Cited Medium: Print ISSN: 2039-7275 (Print)

Record details

×
Academic Journal

Interim-PET predicts progression-free survival in stage IV Hodgkin lymphoma treated with upfront brentuximab vedotin-AVD.

  • Authors : Rusconi C; Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy.; Barone A

  • Source: Leukemia & lymphoma [Leuk Lymphoma] 2025 Jan 11, pp. 1-9. Date of Electronic Publication: 2025 Jan 11.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Metabolic Sequelae and Quality of Life in Early Post-Treatment Period in Adolescents with Hodgkin Lymphoma.

  • Authors : Pranjić I; Croatian Academic Centre for Applied Nutritional Science, 10000 Zagreb, Croatia.; Sila S

  • Source: Journal of clinical medicine [J Clin Med] 2025 Jan 09; Vol. 14 (2). Date of Electronic Publication: 2025 Jan 09.Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101606588 Publication Model: Electronic Cited Medium: Print ISSN: 2077-0383

Record details

×
  • 1-10 of  4,497 results for ""hodgkin lymphoma""